Incyte Corp
(BSP:I1NC34)
R$
221.1
0 (0%)
Market Cap: 85.19 Bil
Enterprise Value: 74.99 Bil
PE Ratio: 552.00
PB Ratio: 4.70
GF Score: 77/100 
Incyte Corp at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 05:40PM GMT
Release Date Price:
R$164.3
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Good morning, and thanks for joining us again here at the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the senior SMID biotech analysts here.
Our next presenting company is Incyte. And sitting up here on stage with me are two members of the management team. To my right is Christiana Stamoulis, who is Executive VP and CFO; and to my left is Steven Stein, who is Chief Medical Officer.
Christiana and Steven, good morning, and thanks for making the trip out West.
Steven H. Stein
Incyte Corporation - Executive VP & Chief Medical Officer
Good morning.
Christiana Stamoulis
Incyte Corporation - Executive VP & CFO
Good Morning. And thank you for inviting us.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
So I think Incyte is a pretty well established company, but just for formality,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers